Clinical Trial

Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated December 30, 2025 (before its estimated June 16, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized, double-blind, placebo-controlled phase IIa clinical trial to evaluate the efficacy and safety of YN001 in patients with atherosclerotic cardiovascular and cerebrovascular diseases and erectile dysfunction
Trial Details
NCT Number NCT07311330
Lead Sponsor Beijing Inno Medicine Co., Ltd.
Conditions Atherosclerotic Cardiovascular Disease (ASCVD), Erectile Dysfunction
Enrollment 40 participants
Start Date 2026-01-31
Primary Completion 2026-06-16 (estimated)
Study Completion 2026-11-14 (estimated)
Updated on ClinicalTrials.gov 2025-12-30